January 7, 2022

This session will address Maryland’s response to the COVID pandemic featuring Novavax, a vaccine company in Gaithersburg, MD which has received a 1.6b grant from the US government to develop its COVID19 vaccine. Throughout its history, Novavax has been enhancing global health by developing vaccines against diseases such as influenza, RSV, Ebola, MERS, SARS, and COVID-19. At this webinar learn how companies such as Novavax and its partners, Maryland Tech Council and The Biotechnology Innovation Organization, are working together to expedite vaccine development, and how they are overcoming the business and scientific challenges that they encounter. The panel will also discuss the economic growth that has resulted in the Maryland biotechnology sector.

Speaking Out, Standing Tall

November 9, 2022

It’s 2019 and I am in the cafeteria at my high school in New Jersey. The room is buzzing around me. I’m s…

Supercharged Networking and Partnership

September 1, 2022

The World Trade Center Institute (WTCI) works with globally-minded business leaders every day. But few in our vast ne…

Finding the Path to Success

July 29, 2022

College was never part of the plan. For Yasmine Bryant, joining the United States Air Force was the natural next step…

Expanding Horizons in Your Own Backyard

June 28, 2022

A commonly repeated refrain suggests that the best way to climb the corporate ladder and see pay bumps is to find a n…

A Healthy Outlook

June 1, 2022

Keren Herrán tried to look at COVID-19 as an opportunity. In the spring of 2020, internships and summer jobs w…

Making Fruitful Connections

May 12, 2022

It has been nearly four years since it happened. And she’s been through a global pandemic. But Aeliana Lomax re…